Early detection of bladder cancer: PreventID® Bladder
- Combined screening for two markers: higher safety in cancer screening
Frequently asked questions
How does PreventID® Bladder work?
PreventID® Bladder is an immunochemical rapid test for doctors. It screens for two markers, a bladder cancer marker called CFHRs (complement factor H-related proteins) and haemoglobin, in the patients’ urine.
Whom was this test developed for?
PreventID® Bladder tests may only be conducted by trained health professionals. It is suitable for near patient screening for bladder cancer at the doctor’s office.
How long does the test take?
12 minutes overall: 2 minutes to prepare, 10 minutes for the actual test.
How accurate is this test?
The bladder cancer marker BCM has been scientifically proven to be a marker for bladder tumours. Additionally, a patient’s urine is also screened for a second marker, i.e. haemoglobin, as bladder tumours occasionally bleed, which can lead to trace amounts of blood in the patient’s urine. Studies have shown, that screening for both of these markers leads to earlier detection of bladder tumours.